Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Devidas, S.
Right arrow Articles by Guggino, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Devidas, S.
Right arrow Articles by Guggino, W. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 45, 29373-29380, November 6, 1998


The Second Half of the Cystic Fibrosis Transmembrane Conductance Regulator Forms a Functional Chloride Channel*

Sreenivas Devidas, Hongwen Yue, and William B. GugginoDagger

From the Department of Physiology and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The cystic fibrosis transmembrane conductance regulator (CFTR) consists of two transmembrane domains (TMDs), TMD1 and TMD2, two cytoplasmic nucleotide binding domains (NBDs), NBD1 and NBD2, and a regulatory domain. To elucidate the complex function of the CFTR, deletion constructs encompassing the second half of the CFTR distal to the first transmembrane domain were expressed in Xenopus oocytes and IB3 cells (a cystic fibrosis cell line). Constructs containing the regulatory domain, the second transmembrane domain, and the second nucleotide binding domain formed constitutively active channels, which were further stimulated upon the addition of cAMP. On the other hand, a construct encompassing the second transmembrane domain and the second nucleotide binding domain was stimulated to a small but noticeable extent upon the addition of cAMP. The selectivity of the second-half construct was the same for iodide and chloride, in contrast to the selectivity of wild-type CFTR, which is Cl- > I-. However, both constructs displayed single-channel conductances that were significantly smaller than those displayed by the first half of the CFTR. We conclude that regions of the second transmembrane domain may contribute to the overall channel of the pore, although the first half of the CFTR may confer its selectivity.

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Quinton suggested in 1983 (24) that Cl- transport is defective in CF,1 and 6 years later, cloning of the CF gene and subsequent studies showed that CFTR is indeed a chloride channel (1, 2) with a linear current versus voltage (I/V) relationship and a 9-11-pS single-channel conductance. The selectivity of the channel is Br- > Cl- > I- > F-. Subsequent to the cloning of the CF gene, many investigators have used site-directed mutagenesis to create CFTR cDNAs containing both naturally occurring and artificial mutations. Studies on the consequences of these mutations have shaped our thinking about the structure and function of the protein. For example, a mutant CFTR (TNRCFTR) composed of the first transmembrane domain, the first nucleotide binding domain, and the R domain can form a functional chloride channel with characteristics approaching that of wtCFTR (3, 4). An additional construct composed of only the first six transmembrane-spanning segments of TMD1 also forms an ion channel with selectivity and single-channel conductance identical to that of wild-type CFTR (5). We have previously shown (6) that the ion selectivity and single-channel conductance of Delta 259 CFTR, which contains membrane-spanning segments M5, M6, and the second half of the CFTR, are identical to those of wild-type CFTR. These studies suggest that the major structural components that allow the CFTR to select among different anions reside within TMD1, more specifically, distal to transmembrane segment M4.

Although TMD1 (7, 8) has been studied extensively, the role of the second half of the CFTR in ion conduction is still unresolved. To evaluate the functional contributions of this region of the protein, we generated deletion constructs encompassing the second half of the CFTR (Fig. 1). The cRNA for these mutants was then injected into Xenopus oocytes. Seventy-two h after injection, two-electrode voltage clamp experiments were performed to look for channel activity. The first construct contains the regulatory domain, the second transmembrane domain, and the second nucleotide binding domain of CFTR (RT2N2CFTR). A second construct containing the second transmembrane domain and the second nucleotide binding domain (T2N2CFTR) was also tested for cAMP-stimulated chloride channel activity. Both constructs included the first 159 bases of wtCFTR so as to include the Kozak methionine for translation initiation. Our results suggest that the second half of the CFTR does play a role in Cl- conduction.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Generation of cDNA constructs. Schematic illustrations of the truncations made to the CFTR cDNA. The representation is based on the putative model for wtCFTR (22). Each vertical bar represents an individual transmembrane segment, whereas straight lines are the intra- or extracytosolic loops. Larger rectangles represent the nucleotide binding domains (NBD1 and NBD2), and the oval represents the R domain. M1 is the first functional Kozak methionine used for translation initiation. The first 160 bases of wtCFTR were added to the second-half deletion constructs to include the first Kozak methionine to facilitate translation initiation.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Site-directed Mutagenesis-- The double-stranded mutagenesis method (Stratagene) was used to generate all of the necessary mutations. Both constructs (RT2N2CFTR and T2N2CFTR) were constructed using a wtCFTR plasmid (PBluescript CFTR) as the template. A StuI site (AGGCCT) was created at position 160 using the oligonucleotide CGCCTCTGGAAAAGGCCTGCGTTGTCTCCAAAC, and another StuI site was created at positions 2125 (for RT2N2CFTR) and 2523 (for T2N2CFTR) using oligonucleotides CCTAACTGAGGCCTTACACCGTTTCTCATTAGAAGG and CGAAAAGTGTCACTGGCGCCTCAGGCAAACTTG, respectively. The selection primer used for this method of mutagenesis was one that eliminated the KpnI site on the vector backbone (CGACCTCGAGGGGGGGCCCAGATCTCAGCTTTTGTTCCC). The three oligonucleotides were phosphorylated and added to a mixture of wtCFTR plasmid and mutagenesis buffer, followed by denaturation by boiling at 100 °C for 5 min. The mixture was cooled on ice for 5 min and then at room temperature for 30 min to facilitate the annealing of the primers to the single-stranded template. The oligonucleotides were extended using DNA polymerase and deoxynucleotide triphosphates, followed by ligation with DNA ligase. Any wild-type plasmid that remained was eliminated by digestion with KpnI for 2 h. A mutS strain was then transformed with the digestion mix and spread out on LB-agar plates overnight. Plasmid DNA was extracted from the colonies and redigested with KpnI to eliminate the wild-type plasmids. The remaining undigested plasmids were then retransformed into XL1 supercompetent cells. Plasmids were then extracted from individual colonies and screened for the mutation of interest. Plasmids carrying mutations at both sites (160 and 2125/2523) were ligated after removal of the intervening regions (160-2125 for RT2N2CFTR and 160-2523 for T2N2CFTR) using the Rapid DNA Ligation kit (Life Technologies, Inc.). The sequences were confirmed by sequencing. The newly generated constructs thus had the first 159 bases of wtCFTR so as to include the Kozak methionine to facilitate translation initiation and the second half of the CFTR (2125-4700 for RT2N2CFTR; 2523-4700 for T2N2CFTR).

Shuttling of DNA Fragments into PRSVCFTR for Transfection into Mammalian Cells-- The cDNA fragments encoding the two second-half constructs were excised from their PBQ vector backbones using the restriction enzymes NotI and SalI. These were then subcloned into a PRSVCFTR vector that had been cut with the same two enzymes to excise wtCFTR, followed by ligation using the Rapid DNA Ligation kit (Life Technologies, Inc.).

Preparation of Messenger RNA-- The PBqCFTR vector was linearized with XhoI (New England Biolabs). One µg of the linearized DNA was in vitro-transcribed with T7 RNA polymerase using the manufacturer's protocol (Ambion Megascript Kit; Ambion, Austin, TX).

Transient Transfection of IB3 Cells using Lipofectin-- The methodologies involved have been described in detail by Schwiebert et al. (5).

Xenopus Oocytes Preparation-- The methodologies involved have been described in detail by Morales et al. (4).

Xenopus Oocyte Expression and Recording-- For the expression studies, oocytes were isolated and incubated for 24 h in modified Barth's solution for 24 h before microinjection. Fifty ng of RNA were microinjected into the cytoplasm of the oocytes and incubated at 18 °C for 72 h. Two-electrode voltage clamp experiments were performed on an oocyte immersed in a 1-ml recording chamber filled with frog Ringer solution. The frog Ringer solution used consisted of 115 mM NaCl, 2 mM KCL, 1 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES, pH 7.4. DIDS (500 µM) was used in the frog Ringer solution at all times. To study iodide currents, sodium chloride in the Ringer solution was substituted by an equimolar quantity of sodium iodide. For membrane current measurements, the oocytes were impaled with two electrodes filled with 3 M KCl with resistances of 0.5-2 megaohms. The resting membrane potentials were allowed to stabilize for 15 min and were typically in the range of 38-48 mV. The membrane potentials were clamped to -40 mV using a two-electrode voltage clamp amplifier (AXOCLAMP-2A; Axon Instruments). The voltage protocol used consisted of voltage steps ranging from -80 to +60 mV in increments of 20 mV delivered from a Pentium 133 MHz computer. Data were analyzed using PClamp 6.03 software (Axon Instruments). Experiments were performed at room temperature. The cAMP stimulation mixture consisting of 10 µM forskolin and 1 mM 3-isobutyl-1-methylxanthine was added after recording the baseline current. Ten to 15 min after the addition of the mixture, currents were recorded again to measure channel activity.

36Cl- Efflux Assay-- Cells were seeded at 30-50% confluence and transfected as described previously (5). Cells were washed three times with Ca2+Mg2+-free phosphate-buffered saline (Life Technologies, Inc.) to remove serum. Thirty µl of 36Cl- solution (DuPont New England Nuclear; 1 mCi/ml) were diluted in 9 ml of Ringer's solution, and 1.5 ml of this loading solution were added to each well of a 6-well plate. The plate was incubated for 2-3 h in a 37 °C room. The Ringer's solution for these experiments was a standard HCO3--free, HEPES- and phosphate-buffered, 140 mM NaCl Ringer solution supplemented with 5 mM glucose and titrated to pH 7.45 with 1N NaOH. All efflux runs were performed in a 37 °C room. Each well served as its own control. At time 0, Ringer's solution without cAMP agonists was added and removed immediately. A fresh aliquot of Ringer's solution was added immediately after that, and the efflux run was started. This process was repeated every 15 s until the 1 min time point, at which time 750 µl of Ringer's solution with forskolin (2.5 mM), 8-bromo-cAMP (250 mM), and CPT-cAMP (250 mM) were added and removed every 15 s for the remaining 2 min of the efflux run. At the end of the run, 750 µl of 0.5 N NaOH was added in two aliquots to lyse and recover all of the cell lysate to determine how much labeled chloride had remained in the cells, and this was used to standardize the data. Each sample was diluted in a scintillation mixture, counted in a scintillation counter, and normalized on a Microsoft Excel spreadsheet as the rate of labeled chloride lost from the cells per minute.

Whole Cell Patch-Clamp Recording-- Cells were seeded at 50% confluence and transfected with wild-type, mutant, or truncated CFTR cDNA. The night before recording and approximately 48 h after transfection, transfected cells were trypsinized from 6-well plates, seeded, and concentrated onto Vitrogen (human collagen; Celtrix, Inc., Palo Alto, CA)-coated glass coverslips (Bellco Glass, Vineland, NJ) for patch-clamp recording. Symmetrical 145 mM Tris-Cl solutions were used to study Cl- currents exclusively. Whole cell recording has been described in detail previously (9).

Single-Channel Recording-- Single-channel patch-clamp recording was carried out in the excised inside-out patch-clamp configuration by using conventional procedures. Catalytic subunits of protein kinase A (75 nM; Promega) and Mg-ATP (1 mM; Sigma) were added to cytoplasmic face of excised patches to activate the channel. All single-channel patch-clamp studies were performed at 25 °C. Integrity of the cell-attached patch was confirmed by visualizing the membrane patch ripping away from the cell, because the patch was excised from the inside-out configuration. Currents were amplified with an Axopatch 200B patch-clamp amplifier and recorded on videotape for later analysis. Data were low-pass filtered at 200 Hz and digitized at 1 kHz. Data were analyzed by pCLAMP6.03 software. A simplex maximum likelihood estimate routine was used to fit the logarithmically binned data (6 bins/decade). The bath solution contained 140 mM N-methyl-D-glutamine chloride, 2 mM MgCl2, 1 mM EGTA, 5 mM HEPES, and 0.5 mM CaCl2 (pH 7.35 with N-methyl-D-glutamine); the pipette solution contained 140 mM N-methyl-D-glutamine chloride, 2 mM CaCl2, and 5 mM HEPES (pH 7.35 with N-methyl-D-glutamine).

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Chloride Channel Studies in Xenopus Oocytes-- To evaluate the functions of the second transmembrane domain of CFTR, cRNA for wtCFTR and the two second-half mutants was expressed in Xenopus oocytes. Water-injected oocytes exhibited little or no current activity in the absence (I = 90.06 ± 6.88 nA, n = 9 at 60 mV; Fig. 2) or presence of cAMP agonists (I = 92.24 ± 7.44 nA, n = 9 at 60 mV). wtCFTR-injected oocytes expressed linear currents upon cAMP stimulation that were DIDS insensitive and exhibited linear I/V characteristics and a reversal potential consistent with a chloride current. The current magnitude was reduced (wtCFTR, ICl- = 534.67 ± 39.7 nA at 60 mV (n = 8) and II- = 410.1 ± 39.7 nA at 60 mV (n = 8); Fig. 3) upon switching to an iodide Ringer solution, consistent with the selectivity profile demonstrated for wtCFTR (Cl- > I-; Ref. 1).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Current characteristics of water-injected oocytes. Representative two-electrode voltage clamp current recordings of water-injected oocytes. Basal, cAMP-stimulated and I/V current characteristics are depicted. The voltage protocol used consisted of a stepwise depolarization, in steps of 20 mV, from -80 to +60 mV with a holding potential of -40 mV. The cAMP stimulation mixture consisting of 10 µM forskolin and 1 mM 3-isobutyl-1-methylxanthine was added 15 min after recording the baseline current. Average whole cell currents at +60 mV are as follows: basal, I = 90.06 ± 6.88 nA, n = 9; cAMP-stimulated current, I = 92.24 ± 7.44 nA, n = 9.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 3.   Current characteristics of wtCFTR-injected oocytes. Representative two-electrode voltage clamp current recordings of wild-type CFTR-injected oocytes. Basal, cAMP-stimulated, and I/V current characteristics are depicted. The voltage protocol used consisted of a stepwise depolarization, in steps of 20 mV, from -80 to +60 mV with a holding potential of -40 mV. The outward rectification of the curves is due to the higher extracellular concentration of chloride (121 mM) compared with that of the inside of the oocyte (40 mM). Average whole cell currents at +60 mV are as follows: basal, I = 115.06 ± 9.16 nA, n = 8; cAMP-stimulated current, ICl- = 534.67 ± 39.7 A, n = 8; II- = 410.1 ± 39.7 nA at 60 mV, n = 8.

On the contrary, oocytes injected with RT2N2CFTR (I = 470.52 ± 84.51 nA at 60 mV) exhibited a large baseline constitutive current compared with those injected with wtCFTR (I = 115.06 ± 9.16 nA, n = 8 at 60 mV; Fig. 4). The current was further increased upon the addition of cAMP agonists (RT2N2CFTR, I = 676.03 ± 87 nA at 60 mV, n = 9; wtCFTR, I = 534.67 ± 39.7 nA at 60 mV, n = 8). The current magnitude was unchanged upon switching the Ringer solution from one in which the predominant anion was chloride to one in which the predominant anion was iodide. This was in contrast to wtCFTR-injected oocytes, in which a decrease in current magnitude was observed upon switching to an iodide-containing Ringer's solution.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 4.   Current characteristics of RT2N2CFTR-injected oocytes. Representative two-electrode voltage clamp current recordings of RT2N2CFTR-injected oocytes. Basal, cAMP-stimulated, and I/V current characteristics are depicted. The voltage protocol used consisted of a stepwise depolarization, in steps of 20 mV, from -80 to +60 mV with a holding potential of -40 mV. Average whole cell currents at +60 mV are as follows: basal, I = 470.52 ± 84.51 nA, n = 9; cAMP-stimulated current, I = 676.03 ± 87 nA, n = 9. The current magnitude was unchanged upon switching to a Ringer solution in which the predominant anion was iodide.

Oocytes injected with cRNA for T2N2CFTR exhibited a small baseline current similar to that exhibited by wtCFTR-injected oocytes (Table I, I = 86.47 ± 6.62 nA, n = 8 at 60 mV; Fig. 5). However, the addition of cAMP agonists increased the current magnitude by only 10-20% compared with wtCFTR (I = 175.38 ± 17.46 nA, n = 8 at 60 mV). There was, however, no change in current magnitude upon switching to an iodide-containing Ringer's solution.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Cl- currents in cRNA-injected oocytes
Current values are shown for all mutants immediately before and 15 min after the application of cAMP agonists (see "Materials and Methods") at the 60 mV clamped voltage.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 5.   Current characteristics of T2N2CFTR-injected oocytes. Representative two-electrode voltage clamp current recordings of T2N2CFTR-injected oocytes. Basal, cAMP-stimulated, and I/V current characteristics are depicted. The voltage protocol used consisted of a stepwise depolarization, in steps of 20 mV, from -80 to +60 mV with a holding potential of -40 mV. Average whole cell currents at +60 mV are as follows: basal, I = 86.47 ± 6.62 nA, n = 8; cAMP-stimulated current, I = 175.38 ± 17.46 nA, n = 8.

Chloride Channel Studies in IB3-1 Cells-- To assess the Cl- channel functions of CFTR, paired 36Cl- efflux assays without and with a cAMP agonist mixture (2.5 µM forskolin and 250 µM 8-chlorophenylthio-cAMP or CPT-cAMP) were performed in IB3-1 cells. IB3-1 cells are a CF bronchial epithelial cell line used extensively to study CFTR function. The experiments were performed as an initial screen to assess whether an individual CFTR mutant could restore cAMP-stimulated efflux of labeled chloride. Parental IB3-1 cells and mock-transfected IB3-1 cells failed to respond to cAMP agonists (Table II), which is typical of CF cells. Wild-type-, Delta 259-M265-, RT2N2CFTR-, and T2N2CFTR- transfected cells, however, all responded to cAMP agonists as predicted from oocyte recordings (Table II). Surprisingly, cells transfected with T2N2CFTR also demonstrated an increase in efflux upon cAMP stimulation that was similar to that exhibited by cells transfected with wtCFTR. This could be attributed to a larger number of channels being formed on the plasma membrane.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Cl- efflux analysis in IB3-1 cells
36Cl- efflux of labeled chloride from IB3-1 CF cells is shown. The before agonists value is the rate of 36Cl- efflux immediately before stimulation with cAMP agonists (2.5 µM forskolin and 250 µM CPT-cAMP). The after agonists value is the peak stimulated rate after the addition of cAMP agonists.

Whole cell current patch-clamp recordings were carried out to assess the Cl- channel function of wild-type CFTR and the second-half mutants in IB3-1 cells, a CF cell line. Mock-transfected cells failed to exhibit cAMP-stimulated chloride currents (Fig. 6A). However, cells transfected with wtCFTR exhibited cAMP-stimulated currents that were DIDS insensitive (Fig. 6B). Cells transfected with RT2N2CFTR exhibited a larger baseline compared with those transfected with wtCFTR. When stimulated, RT2N2CFTR-transfected cells generated currents comparable to those of wtCFTR-transfected cells (Fig. 6C). On the other hand, cells transfected with T2N2CFTR exhibited a small baseline current comparable to that of wtCFTR-transfected cells and were stimulated to a smaller extent upon the addition of cAMP agonists (Fig. 6D). Single-channel analysis of the mutant constructs in excised inside-out patches also revealed chloride channels with significantly smaller conductances than that of wtCFTR (Table III; Fig. 7), whereas wtCFTR had a conductance of 10.2 pS, compared with a conductance of 4 pS for RT2N2CFTR and 3.8 pS for T2N2CFTR. Interestingly enough, both constructs were nonselective for the halides chloride or iodide, in contrast with wild-type CFTR, which was more selective for chloride than iodide.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 6.   Whole cell currents of wild-type and deletion mutants of CFTR expressed in cultured bronchial CF epithelial cells (IB3-1). A, Mock, representative whole cell patch-clamp recordings of the cAMP-stimulated and DIDS-insensitive component of cAMP-stimulated Cl- currents in wild-type CFTR-transfected IB3-1 cells. A very small basal current was observed that was not increased upon cAMP stimulation. B, wtCFTR, representative whole cell patch-clamp recordings of the cAMP-stimulated and DIDS-insensitive component of cAMP-stimulated Cl- currents in wild-type CFTR-transfected IB3-1 cells (n = 5). cDNA constructs were transfected transiently into IB3-1 CF cells and studied in physiological assays 72 h after transfection in comparison with wild-type CFTR, mock-transfected cells, and parental IB3-1 cells. DIDS (500 µM) inhibited the outwardly rectifying current, whereas the remaining, underlying linear current (CFTR current) was unaffected (-100 to +100 mV in 20-mV increments from a holding voltage of 0 mV). C, RT2N2CFTR, typical whole cell patch-clamp recordings of cAMP-stimulated DIDS inhibition of cAMP-stimulated Cl- currents from a RT2N2CFTR-transfected cell (n = 5). D, T2N2CFTR, representative whole cell patch-clamp recordings of a cAMP-T2N2CFTR-transfected cell (n = 5); DIDS (500 µM) failed to inhibit the current observed, indicating that the linear current was due exclusively to the CFTR channel activity.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Single-channel characteristics of the second-half of CFTR in IB3-1 CF cells
Single-channel patch-clamp recording from IB3-1 CF cells transfected with wt-CFTR, RT2N2-CFTR, and T2N2-CFTR is shown. Use of 50% threshold-crossing method to determine Po. Permeability ratios were calculated from reversal potentials with the Goldman-Hodgkin-Katz equation.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 7.   Single-channel current characteristics of wild-type CFTR and deletions in IB3-1 cells. Representative single-channel traces from an excised, inside-out membrane patch from IB3-1 cells transfected with either mock, wtCFTR, RT2N2CFTR, or T2N2CFTR. Downward deflections indicate channel openings. The holding potential Vm was -75 mV. Catalytic subunits of protein kinase A (75 nM; Promega) and Mg-ATP (1 mM; Sigma) were added to the cytoplasmic face of excised patches to activate the channel.


    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The importance of TMD2 for the normal functioning of the CFTR is evident in the large number (19 thus far) of missense mutations associated with CF located in the fourth intracellular loop (ICL4) between segments M10 and M11 of CFTR (10-14). One residue in particular, R1066, is associated with four separate CF-causing mutations. Cotten et al. (15) constructed several of these mutants and expressed them in heterologous cells to study their effects on protein processing and function. These mutants expressed chloride currents upon cAMP stimulation, which had close to wild-type characteristics. The single-channel conductances and anion selectivity of these mutants resembled that of wild-type CFTR, suggesting that ICL4 does not contribute directly to the conduction pore. However, the mutants did have varied influences on the open state probability and burst duration. The authors speculate that ICL4 mutations might disrupt or modify some aspect of gating of the Cl- channel pore but not the conduction of anions through the pore. Siebert et al. (16) conducted similar experiments on the third intracellular loop of CFTR and concluded that this region may be involved in maintaining the stability of the channel in the open state.

Fluorescence assays on peptides corresponding to the individual transmembrane segments revealed that membrane-spanning regions in the second half were able to conduct chloride and could thus line the pore in the wild-type protein. McCarty et al. (17) and McDonough et al. (18) studied the diphenylamine-2-carboxylic acid binding properties of residues within the putative chloride permeation pathway of CFTR. Residues in CFTR that exhibit altered diphenylamine-2-carboxylic acid binding properties when mutated may line the pore. They showed that residues in both M6 and M12 may line the channel pore, suggesting that regions of the second half of the CFTR may line the channel pore.

Anderson et al. (1) mutated several amino acids in the TMDs and evaluated their effects on CFTR channel function. They hypothesized that if the charged amino acids that lined the channel were mutated, they would disrupt the wild-type electrical forces in the pore, thereby influencing ion selectivity. Lys95 in M1 and Lys335 in M6 were mutated to Asp and Glu, respectively. HeLa cells were transfected with wtCFTR or with the mutants. Analysis of whole cell cAMP-stimulated chloride currents showed that these lysine mutations altered wild-type ion selectivity from Br- > Cl- > I- > F- to I- > Br- > Cl- > F-. In contrast, the mutation of Arg347 in M6 and Arg1030 in M10 did not induce major differences in halide selectivity compared with wtCFTR. From these data, they concluded that the residues in TMD1 play an important role in the selectivity filter of the CFTR.

The results from our studies suggest that regions of the second half of CFTR may line the channel pore and have important contributions to its chloride channel function, whereas the selectivity filter of CFTR is provided by charged residues on the sixth transmembrane segment (M6) of wtCFTR. We have shown that expression of the second half of CFTR distal to the first nucleotide binding domain generated functional chloride channels albeit with properties distinct from that of wild-type CFTR. RT2N2CFTR produces Cl- currents that are stimulated by cAMP. On the other hand, T2N2CFTR generated a smaller increase in current upon cAMP stimulation. This could be due to the fact that T2N2CFTR has no consensus phosphorylation sites, whereas RT2N2CFTR retains most of the phosphorylation sites that lie in the R domain. In the case of the wild-type protein, phosphorylation of the R domain followed by ATP binding and hydrolysis causes the opening of the channel. In the case of RT2N2CFTR, the R domain is unable to keep the channel closed in the basal or unstimulated state. This could suggest that in the absence of the first transmembrane domain and the first nucleotide binding domain, the R domain is unable to form a regulated channel. Furthermore, the first two domains may be necessary for the R domain to keep the channel closed in the unstimulated state. The observation that T2N2CFTR channels were not stimulated significantly upon the addition of cAMP agonists is not surprising because this construct lacks any consensus PKA phosphorylation sites. Furthermore, NBD1 has been shown to be responsible for the opening of the channel, whereas NBD2 has been shown to be associated with channel closing. The presence of NBD2 in this construct could also result in the longer closure of these channels and, subsequently, a smaller stimulation of the channels. The smaller conductance exhibited by these second-half constructs could suggest that the overall conductance of CFTR is provided by TMD1 and TMD2. TNRCFTR, which contains the first transmembrane domain, the first nucleotide domain, and the R domain, displays a conductance (8 pS) almost equal to that of wtCFTR, whereas the second-half constructs discussed above show much smaller conductances (RT2N2CFTR, 4 pS; T2N2CFTR, 3.8 pS). This could suggest that the major contribution to the size of the pore comes from the first half of the protein, whereas regions of the second half could contribute a smaller part.

The results summarized above suggest that the second half of CFTR has important functions in the overall tertiary structure of the channel. The regions of the second half distal to the second nucleotide binding domain may also play important roles in the regulatory interactions of CFTR with the outwardly rectifying chloride channel, the epithelial sodium channel, and other potassium channels. Finally, the discovery of proteins that facilitate interactions between membrane proteins via interactions at the amino and carboxyl termini could add importance to the second half of CFTR. There is growing evidence that proteins with PDZ domains do interact with other ion channels (19, 20). Expression of proteins containing these domains causes a clustering of ion channels and receptors at the plasma membrane. For instance, coexpression of PSD-95 (a PDZ domain-containing protein) results in clustering of voltage gated K+ channels and N-methyl-D-aspartate receptors at the plasma membrane (19). The PSD-95 protein recognizes a specific sequence present at both the carboxyl termini of the Shaker voltage gated K+ channel and the NR2 subunit of the N-methyl-D-aspartate receptor. Similar domains have also been identified recently for CFTR (21). Furthermore, several such proteins have been discovered that interact with the carboxyl-terminal of CFTR, rendering this region of the protein to be of greater importance than previously thought (21-23).2

    FOOTNOTES

* This work was supported by the Cystic Fibrosis Foundation Research Development Program and National Institutes of Health Grants HL 51811, HL 47122, and DK 48977 (to W. B. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Physiology and Pediatrics, Johns Hopkins University School of Medicine, 725 N. Wolfe St., Baltimore, MD 21205. Tel.: 410-955-7166; Fax: 410-955-0461; E-mail: wguggino{at}bs.jhmi.edu.

The abbreviations used are: CF, cystic fibrosis; CFTR, CF transmembrane conductance regulator; TMD, transmembrane domain; NBD, nucleotide binding domain; R, regulatory; wt, wild-type; DIDS, 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid.

2 J. Cheng, personal communication.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

  1. Anderson, M. P., Rich, D. P., Gregory, R. J., Smith, A. E., and Welsh, M. J. (1991) Science 251, 679-682[Abstract/Free Full Text]
  2. Anderson, M. P., Gregory, R. J., Thompson, S., Souza, D. W., Paul, S., Mulligan, R. C., Smith, A. E., and Welsh, M. J. (1991) Science 253, 202-205[Abstract/Free Full Text]
  3. Sheppard, D. N., Ostedgaard, L. S., Rich, D. P., and Welsh, M. J. (1994) Cell 76, 1091-1098[CrossRef][Medline] [Order article via Infotrieve]
  4. Morales, M. M., Carroll, T. P., Morita, T., Schwiebert, E. M., Devuyst, O., Wilson, P. D., Lopes, A. G., Stanton, B. A., Dietz, H. C., Cutting, G. R., and Guggino, W. B. (1996) Am. J. Physiol. 270, F1038-F1048[Abstract/Free Full Text]
  5. Schwiebert, E. M., Morales, M. M., Devidas, S., Egan, M. E., and Guggino, W. B. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2674-2679[Abstract/Free Full Text]
  6. Carroll, T. P., Morales, M. M., Fulmer, S. B., Allen, S. S., Flotte, T. R., Cutting, G. R., and Guggino, W. B. (1995) J. Biol. Chem. 270, 11941-11946[Abstract/Free Full Text]
  7. Akabas, M. H., Kaufmann, C., Cook, T. A., and Archdeacon, P. (1994) J. Biol. Chem. 269, 14865-14868[Abstract/Free Full Text]
  8. Cheung, M., and Akabas, M. H. (1996) Biophys. J. 70, 2688-2695[Abstract/Free Full Text]
  9. Schwiebert, E. M., Egan, M. E., Hwang, T. H., Fulmer, S. B., Allen, S. S., Cutting, G. R., and Guggino, W. B. (1995) Cell 81, 1063-1073[CrossRef][Medline] [Order article via Infotrieve]
  10. Ferec, C., Audrezet, M. P., Mercier, B., Guillermit, H., Moulllier, P., Querec, I., and Verlingue, C. (1992) Nat. Genet. 1, 188-191[CrossRef][Medline] [Order article via Infotrieve]
  11. Fanen, P., Ghanem, N., Vidaud, M., Besmond, C., Martin, J., Costyes, B., Plassa, F., and Goossens, M. (1992) Genomics 13, 770-776[CrossRef][Medline] [Order article via Infotrieve]
  12. Mercier, B., Lissens, W., Novelli, G., Kalaydjiev, L., DeArce, M., Kapranov, N., Canki-Klain, N., Lenoir, G., Chauveau, P., Lenaerts, C., Rault, S., Cashman, S., Sanguiolo, F., Audrezet, M. P., Dallapiccola, B., Guillermit, H., Bonduelle, M., Liebaers, I., Querec, I., Verlingue, C., and Ferec, C. (1993) Genomics 16, 296-297[CrossRef][Medline] [Order article via Infotrieve]
  13. Ghanem, N., Costes, B., Giorodon, E., Martin, J., Fanen, P., and Goossens, M. (1994) Genomics 21, 434-436[CrossRef][Medline] [Order article via Infotrieve]
  14. Savov, A., Mercier, B., Kalaydjiev, L., and Ferec, C. (1994) Hum. Mol. Genet. 3, 57-60[Abstract/Free Full Text]
  15. Cotten, J. F., Ostedgaard, L. S., Carson, M. R., and Welsh, M. J. (1996) J. Biol. Chem. 271, 21279-21284[Abstract/Free Full Text]
  16. Siebert, F. S., Lindsell, P., Loo, T. W., Hanrahan, J. W., Riordan, J. R., and Clarke, D. M. (1996) J. Biol. Chem. 271, 27493-27499[Abstract/Free Full Text]
  17. McCarty, N. A., McDonough, S., Cohen, B. N., Riordan, J. R., Davidson, N., and Lester, H. A. (1993) J. Gen. Physiol. 102, 1-23[Abstract/Free Full Text]
  18. McDonough, S., Davidson, N., Lester, H. A., and McCarty, N. A. (1994) Neuron 13, 623-634[CrossRef][Medline] [Order article via Infotrieve]
  19. Kim, E., Niethammer, M., Rothschild, A., Jan, Y. N., and Sheng, M. (1995) Nature 378, 85-88[CrossRef][Medline] [Order article via Infotrieve]
  20. Kim, E., Cho, K. O., Rothschild, A., and Sheng, M. (1996) Neuron 17, 103-113[CrossRef][Medline] [Order article via Infotrieve]
  21. Wang, S., Raab, R. W., Schatz, P. J., Guggino, W. B., and Li, M. (1998) FEBS Lett. 427 (1), 103-108[CrossRef][Medline] [Order article via Infotrieve]
  22. Short, D. B., Trotter, K. W., Reczek, D., Kreda, S. M., Bretscher, A., Boucher, R., Stutts, J., and Milgram, S. L. (1998) J. Biol. Chem. 273, 19797-19801[Abstract/Free Full Text]
  23. Hall, R. A., Ostedgaard, L. S., Premont, R. T., Blitzer, J. T., Rahman, N., Welsh, M. J., and Lefkowitz, R. J. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 8496-8501[Abstract/Free Full Text]
  24. Quinton, P. M. (1983) Nature 301, 421-422[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. M. Lewarchik, K. W. Peters, J. Qi, and R. A. Frizzell
Regulation of CFTR Trafficking by Its R Domain
J. Biol. Chem., October 17, 2008; 283(42): 28401 - 28412.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z.-R. Zhang, G. Cui, X. Liu, B. Song, D. C. Dawson, and N. A. McCarty
Determination of the Functional Unit of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel: ONE POLYPEPTIDE FORMS ONE PORE
J. Biol. Chem., January 7, 2005; 280(1): 458 - 468.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. De la Vieja, O. Dohan, O. Levy, and N. Carrasco
Molecular Analysis of the Sodium/Iodide Symporter: Impact on Thyroid and Extrathyroid Pathophysiology
Physiol Rev, July 1, 2000; 80(3): 1083 - 1105.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yue, S. Devidas, and W. B. Guggino
The Two Halves of CFTR Form a Dual-pore Ion Channel
J. Biol. Chem., March 31, 2000; 275(14): 10030 - 10034.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Biol.Home page
N. McCarty
Permeation through the CFTR chloride channel
J. Exp. Biol., January 7, 2000; 203(13): 1947 - 1962.
[Abstract] [PDF]


Home page
Physiol. Rev.Home page
D. N. SHEPPARD and M. J. WELSH
Structure and Function of the CFTR Chloride Channel
Physiol Rev, January 1, 1999; 79(1): 23 - 45.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Van Oene, G. L. Lukacs, and J. M. Rommens
Cystic Fibrosis Mutations Lead to Carboxyl-terminal Fragments That Highlight an Early Biogenesis Step of the Cystic Fibrosis Transmembrane Conductance Regulator
J. Biol. Chem., June 23, 2000; 275(26): 19577 - 19584.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Cahill, M. W. Nason Jr., C. Ambrose, T.-Y. Yao, P. Thomas, and M. E. Egan
Identification of the Cystic Fibrosis Transmembrane Conductance Regulator Domains That Are Important for Interactions with ROMK2
J. Biol. Chem., May 26, 2000; 275(22): 16697 - 16701.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow